RetinalGenix Technologies Inc
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remot… Read more
RetinalGenix Technologies Inc (RTGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.048x
Based on the latest financial reports, RetinalGenix Technologies Inc (RTGN) has a cash flow conversion efficiency ratio of 0.048x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-103.84K) by net assets ($-2.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RetinalGenix Technologies Inc - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how RetinalGenix Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
RetinalGenix Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RetinalGenix Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AFFLUENT MEDICAL SAS EO 1
F:0JZ
|
N/A |
|
Camil Alimentos S.A
SA:CAML3
|
0.102x |
|
AleAnna, Inc. Class A Common Stock
NASDAQ:ANNA
|
0.154x |
|
DE&T Co. Ltd
KQ:079810
|
0.053x |
|
Bellavista Resources Ltd
AU:BVR
|
-0.067x |
|
Tune Protect Group Bhd
KLSE:5230
|
0.004x |
|
Sandfire Resources America Inc
OTCQB:SRAFF
|
0.050x |
|
Flag Ship Acquisition Corp. Unit
NASDAQ:FSHPU
|
-0.006x |
Annual Cash Flow Conversion Efficiency for RetinalGenix Technologies Inc (2020–2024)
The table below shows the annual cash flow conversion efficiency of RetinalGenix Technologies Inc from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.46 Million | $-741.94K | 0.507x | +57.87% |
| 2023-12-31 | $-1.41 Million | $-451.66K | 0.321x | +72.37% |
| 2022-12-31 | $-1.07 Million | $-199.29K | 0.186x | -92.58% |
| 2021-12-31 | $-464.68K | $-1.17 Million | 2.511x | -85.81% |
| 2020-12-31 | $-80.36K | $-1.42 Million | 17.700x | -- |